Stem Cell Research and Pay-to-Participate Trials
Typically, patients do not have to pay to participate in clinical trials; however, as research funding continues to shrink, the growth of pay-to-participate trials has increased. STEM CELLS Translational Medicine hosted a panel discussion on Stem Cell Research and Pay-to-Participate Trials to better address the growing concerns of clinical trial research and financial conflicts of interest. The panel examined the benefits of this research funding model as well the potentials for misuse and ethical concerns.
Anthony Atala, MD - Director, Wake Forest Institute for Regenerative Medicine
Arthur L. Caplan, PhD - Drs. William F. and Virginia Connolly Mitty Professor of Bioethics in the Department of Population Health, NYU Langone
Nancy M.P. King, JD - Professor, Social Sciences and Health Policy, Wake Forest University
Susan Z. Kornetsky, MPH - Director of Clinical Research Compliance, Boston Children's Hospital
Leigh Turner, PhD - Professor of Health, Society, & Behavior, UC Irvine Public Health